Everest Group Reports Robust Q4 Earnings

Everest Group reported a sharp turnaround in Q4 2025 with net income of $446 million versus a $593 million loss a year earlier and EPS of $10.77 compared with a loss per share of $13.96; quarterly revenues were $4.42 billion (down from $4.64 billion) as premiums earned dipped to $3.86 billion, pressured by lower investment gains. For full-year 2025, net income rose to $1.59 billion from $1.37 billion, EPS increased to $37.80 from $31.78, and revenues grew to $17.50 billion supported by higher net investment income; the shares closed at $333.42, up 1.09% on the NYSE.

Analysis

Market structure: EG’s return to profitability (Q4 EPS $10.77; close $333.42) benefits reinsurers and asset managers that rely on stable float and investment income; cedants (primary insurers) could face slightly higher reinsurance pricing if EG leverages underwriting strength. The modest revenue decline (premiums earned down ~1.8% q/q year-on-year) suggests underwriting discipline rather than volume-driven growth—pricing power is improving but not runaway. Cross-asset: stronger insurer results can tighten corporate credit spreads in financials and put modest upward pressure on equities vs. corporate bonds; a 25–50bp move in 10y yields would materially change EG’s net investment income assumptions over 12–24 months.

Risk assessment: Key tail risks are large catastrophe losses or adverse reserve development that could erase the $1.59bn FY gain; regulatory capital changes or retrocession market shocks are 1–2% probability but high impact. Near term (days-weeks) volatility centers on management commentary and any reserve releases; medium-term (3–12 months) risk is investment performance vs. rising rates and credit losses. Hidden dependency: portion of improvement came from investment income—if markets correct 10–15% that benefit reverses; catalysts include catastrophe season, Fed moves, and reinsurance renewals (next 3–6 months).

Trade implications: Direct long EG (ticker EG) biased but size-constrained: favorable risk/reward if entry below $340 with 12–18 month horizon due to EPS leverage. Use relative-value: long EG vs short RNR (RenaissanceRe) or RE (Everest Re) if those show weaker investment yield exposure—target spread capture of 5–10% over 6–12 months. Options: sell near-term covered calls to harvest premium and buy 9–12 month OTM calls (LEAP) for convex upside while funding with short-dated puts to improve yield.

Contrarian angles: Consensus may underprice reserve volatility and overprice sustainability of 2025 investment gains—market might be underestimating frequency/severity tail losses. Reaction is likely underdone: a 5–10% stock move higher on headline EPS masks binary downside from a single catastrophic event; historical parallels include 2005/2011 reinsurance spikes where earnings reverted quickly. Unintended consequence: chasing yield through options income can leave portfolios exposed to sudden headline losses; preserve liquidity and maintain 8–12% stop-loss thresholds on directional exposure.

Key Decisions for Investors

• Establish a 2–3% long equity position in EG at market up to $340, add another 1–2% on any dip to $300–320, target 12–18 month horizon and trim into a 15–25% rally; set preliminary stop-loss at -12% from entry.
• Construct a pair trade: long EG (2%) vs short RNR or RE (1.5%) to exploit superior reported EPS/momentum; close if spread widens/narrows by 7–10% in 3–9 months or after 2 consecutive quarters of divergent reserve revisions.
• Implement an options collar: buy 12-month EG 375 calls (LEAP) funded by selling 1–2 month 5–10% OTM covered calls repeatedly; simultaneously sell 3–6 month 15% OTM puts to generate premium, limit aggregate downside to ~10% net.
• Reduce non-core exposure to broader property/casualty insurers by 2–4% in favor of reinsurance exposure if 10y Treasury yield breaches 4.5% (signal that investment income repricing is likely to stall); reassess after next reinsurance renewal season (90–180 days).